INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

People assigned to a diet, food or program and measured.

256 studies · page 10 of 11

2007 / Double-blind, placebo-controlled randomized trial

Oral intake of 40 mg/day of soy isoflavone aglycone improved fine wrinkles and malar skin elasticity in middle-aged women.

Twenty-six women in their late 30s and early 40s were randomly assigned to receive 40 mg/day of soy isoflavone aglycone (13 women) or placebo (13 women) for 12 weeks. Compared with placebo, the soy isoflavone aglycone group showed statistically significant improvement in fine wrinkles at week 12 (p<0.05) and malar skin elasticity at week 8 (p<0.05). Skin microrelief at the lateral angle of the eyes did not significantly differ between groups, though an intragroup improvement occurred at week 8 in the test group (p<0.05). No adverse symptoms were reported during the study.

Izumi T, Saito M, Obata A, et al. J Nutr Sci Vitaminol (Tokyo), 2007. PMID 17484381

2007 / Randomized controlled trial

Annual intramuscular vitamin D injection did not prevent non-vertebral fractures in older adults.

A randomized, double-blind, placebo-controlled trial evaluated 9,440 adults aged 75 and older who received an annual intramuscular injection of 300,000 IU vitamin D2 or placebo over 3 years. Vitamin D did not significantly reduce non-vertebral fractures (HR 1.09, 95% CI 0.93-1.28) or falls (HR 0.98, 95% CI 0.93-1.04). However, hip fracture risk was increased in the vitamin D group (HR 1.49, 95% CI 1.02-2.18).

Smith H, Anderson F, Raphael H, et al. Rheumatology (Oxford), 2007. PMID 17998225

2007 / Randomized controlled trial

Long-term beta carotene supplementation for 18 years significantly improved cognitive performance in older men.

Cognitive testing was added near the close of the beta carotene arm (50 mg, alternate days) of the Physicians' Health Study II to assess general cognition, verbal memory, and category fluency in 5,956 men aged >65 years. Among 1,904 new recruits with a mean treatment duration of 1 year, cognition was similar between beta carotene and placebo groups. Among 4,052 continuing participants with a mean treatment duration of 18 years, the beta carotene group had a significantly higher mean global score (mean difference in z scores, 0.047; P = .03) and verbal memory score (mean difference in z scores, 0.063; P = .007) compared with placebo.

Grodstein F, Kang JH, Glynn RJ, et al. Arch Intern Med, 2007. PMID 17998490

2006 / Randomized, cross-over trial

A soy-rich diet did not relieve urogenital symptoms or improve vaginal health in perimenopausal and postmenopausal Thai women.

Thirty-six perimenopausal and postmenopausal women participated in a randomized cross-over trial with two 12-week diet periods (a soy-free control diet and an isocaloric soy-rich diet with 25 g soy protein providing over 50 mg/day of isoflavones) separated and preceded by 4-week washout periods. Symptoms of urge incontinence and vaginal dryness significantly increased after 12 weeks of the soy-free diet, but all other urogenital symptoms remained unchanged in both periods. Furthermore, the vaginal health index, vaginal pH, karyopyknotic index, and maturation value did not significantly change in either period.

Manonai J, Songchitsomboon S, Chanda K, et al. Maturitas, 2006. PMID 16297576

2006 / Double-blind, randomized, controlled, intention-to-treat trial

Neither dietary soy nor flaxseed muffins significantly improved menopause-specific quality of life or hot flash symptoms compared to wheat flour.

A randomized controlled trial evaluated 99 postmenopausal women who consumed muffins containing 25 g of flaxseed (50 mg lignans), 25 g of soy (42 mg isoflavones), or wheat flour daily for 16 weeks. Eighty-seven women completed the study. Across all quality-of-life domains, the treatment-by-time interaction was not significant (P = 0.62), though a significant time main effect occurred (P < 0.0001). Repeated-measures ANCOVA controlling for BMI found no significant group-by-time interactions or group differences for quality of life or hot flash measures, except hot flashes were less severe with flaxseed versus placebo (P = 0.001) without a significant group-by-time interaction. Overall, neither flaxseed nor soy significantly affected menopause-specific quality of life or hot flashes.

Lewis JE, Nickell LA, Thompson LU, et al. Menopause, 2006. PMID 16837885

2006 / Randomized controlled trial (post-hoc subgroup analysis)

Vitamin E's effect on common cold risk varied by age, smoking intensity, and residential neighborhood in older male smokers.

Researchers analyzed 14,573 male smokers from the placebo and vitamin E (50 mg/day) arms of the ATBC Study to explore how age, smoking, and residential neighborhood modified the effect of vitamin E on common cold risk. In participants aged 72 years or older at follow-up, vitamin E reduced common cold risk among those smoking 5-14 cigarettes per day and living in cities (RR = 0.54; 95% CI 0.37-0.80). However, among those smoking more and living away from cities, vitamin E increased common cold risk (RR = 1.58; 95% CI 1.23-2.01).

Hemilä H, Virtamo J, Albanes D, et al. J Am Coll Nutr, 2006. PMID 16943455

2006 / Randomised double-blind placebo-controlled trial

Zinc supplementation showed mixed effects on cognitive measures at 3 months, with no consistent overall cognitive benefit in healthy older adults.

A randomized, double-blind, placebo-controlled trial evaluated the effects of 0 (placebo), 15, or 30 mg/day of zinc supplementation over 3 and 6 months in 387 healthy adults aged 55-87 years. Younger adults (<70 years) outperformed older adults (>70 years) on all tests. For two out of eight dependent variables, significant interactions were observed: both 15 and 30 mg/day showed a beneficial effect at 3 months only on one measure of spatial working memory, whereas 15 mg/day showed a detrimental effect on one measure of attention. The authors note that further research is needed to determine whether findings apply to older adults in poorer health or with less adequate zinc status.

Maylor EA, Simpson EE, Secker DL, et al. Br J Nutr, 2006. PMID 17010236

2006 / Dietary intervention trial

A low-fat, high-carbohydrate dietary intervention did not affect the timing of natural menopause overall in women at higher risk of breast cancer.

Researchers examined the effect of a low-fat, high-carbohydrate (LFHC) dietary intervention on time to menopause in 2,611 premenopausal women with extensive mammographic density followed for an average of 7 years. The LFHC intervention did not affect the time to natural menopause overall (P = 0.72 for log-rank test; n = 699 events). An interaction between study group and baseline BMI was observed (P = 0.01), showing earlier menopause in the intervention group when BMI was low, and later menopause associated with higher BMI only in the intervention group. Greater parity, weight, and education were associated with later menopause, whereas older age at first birth and baseline smoking were associated with earlier menopause.

Martin LJ, Greenberg CV, Kriukov V, et al. Am J Clin Nutr, 2006. PMID 17023721

2006 / Randomized, double-blind, placebo-controlled trial

Long-term vitamin E supplementation did not provide cognitive benefits among generally healthy older women.

In a substudy of the Women's Health Study, 6,377 women aged 65 or older were randomly assigned to receive 600 IU of vitamin E (alpha-tocopherol acetate) on alternate days or placebo. Cognitive assessments were conducted every 2 years by telephone over up to 9.6 years of treatment. No differences in global cognitive score were found between the vitamin E and placebo groups at the first assessment (mean difference, -0.01; 95% CI, -0.04 to 0.03) or at the final assessment (mean difference, 0.00; 95% CI, -0.04 to 0.04). Cognitive change over time was similar between groups (mean difference in change, 0.02; 95% CI, -0.01 to 0.05; P = .16), and the relative risk of substantial cognitive decline was 0.92 (95% CI, 0.77 to 1.10).

Kang JH, Cook N, Manson J, et al. Arch Intern Med, 2006. PMID 17159011

2005 / Double-blind, randomized, placebo-controlled crossover trial

Daily supplementation with 114 mg of isolated soy isoflavones for 3 months did not affect vaginal dryness or endometrial measures in postmenopausal women.

In a double-blind, randomized, placebo-controlled crossover trial, 64 postmenopausal women with a history of breast cancer took 114 mg of isolated isoflavonoids or placebo daily for 3 months, separated by a 2-month washout period. Isolated isoflavones did not relieve vaginal dryness. Vaginal maturation index values remained unchanged during isoflavone treatment but decreased during placebo. No changes were observed in any endometrial variables, including thickness, histology, estrogen and progesterone receptors, or Ki-67 expression.

Nikander E, Rutanen EM, Nieminen P, et al. Fertil Steril, 2005. PMID 15652899

2005 / Double-blind randomized controlled trial

Daily vitamin E supplementation did not reduce the risk of progression from mild cognitive impairment to Alzheimer's disease over three years.

In a double-blind trial, 769 subjects with amnestic mild cognitive impairment were randomly assigned to receive 2000 IU of vitamin E daily, 10 mg of donepezil daily, or placebo for three years. Over three years, possible or probable Alzheimer's disease developed in 212 subjects. Compared to placebo, there were no significant differences in progression to Alzheimer's disease in the vitamin E group (hazard ratio, 1.02; 95% CI, 0.74 to 1.41; P=0.91) or the donepezil group (hazard ratio, 0.80; 95% CI, 0.57 to 1.13; P=0.42). Donepezil reduced progression likelihood during the first 12 months (P=0.04), but vitamin E showed no benefit at any point, including among apolipoprotein E epsilon4 carriers.

Petersen RC, Thomas RG, Grundman M, et al. N Engl J Med, 2005. PMID 15829527

2005 / Randomized, parallel-group, double-blind, dose-finding trial

In older adults with mild vitamin B12 deficiency, daily oral cyanocobalamin doses of 647 to 1032 mcg produced 80% to 90% of maximal methylmalonic acid reduction.

A randomized, parallel-group, double-blind, dose-finding trial evaluated the effects of 16 weeks of daily oral cyanocobalamin (2.5, 100, 250, 500, and 1000 mcg) in 120 older adults with mild vitamin B12 deficiency. Daily doses of 2.5, 100, 250, 500, and 1000 mcg were associated with mean plasma methylmalonic acid reductions of 16%, 16%, 23%, 33%, and 33%, respectively. Daily doses of 647 to 1032 mcg were associated with 80% to 90% of the estimated maximum reduction in plasma methylmalonic acid.

Eussen SJ, de Groot LC, Clarke R, et al. Arch Intern Med, 2005. PMID 15911731

2005 / Double-blind, split-face randomized controlled trial

Topical 5% niacinamide applied for 12 weeks significantly improved wrinkles, skin yellowing, elasticity, and hyperpigmentation in aging facial skin.

Fifty white female subjects with facial photoaging applied 5% niacinamide to half of their face and a vehicle control to the other half twice daily for 12 weeks in a split-face randomized design. Assessments occurred at baseline and at 4-week intervals. Analyses showed significant improvements with topical niacinamide, including reductions in fine lines, wrinkles, hyperpigmented spots, red blotchiness, and skin sallowness, as well as improved elasticity measured via cutometry.

Bissett DL, Oblong JE, Berge CA Dermatol Surg, 2005. PMID 16029679

2005 / Randomized crossover trial

Daily egg consumption raised both LDL and HDL cholesterol without altering their ratio.

A crossover trial evaluated 42 older adults consuming either three eggs daily or an egg substitute for one month separated by a three-week washout. Consuming eggs significantly increased both LDL cholesterol (P < 0.05) and HDL cholesterol (P < 0.001), maintaining stable LDL-to-HDL and total-to-HDL cholesterol ratios. In addition, LDL peak diameter increased during the egg phase, whereas parameters of LDL oxidation did not differ between treatments.

NANO counterpoint →

Greene CM, Zern TL, Wood RJ, et al. J Nutr, 2005. PMID 16317122

2004 / Randomized, placebo-controlled, matched-pairs, double-blind trial

Oral NADH supplementation for 6 months prevented cognitive decline and improved total MDRS scores in patients with Alzheimer's disease.

A 6-month randomized, double-blind, matched-pairs trial evaluated 10 mg/day of stabilized oral NADH versus placebo in 26 patients with probable Alzheimer's disease. After 6 months, patients taking NADH showed no evidence of progressive cognitive deterioration and achieved significantly higher total scores on the MDRS compared with placebo (p < 0.05). Subscale analysis showed significantly better performance with NADH in verbal fluency (p = 0.019) and visual-constructional ability (p = 0.038), with a trend in abstract verbal reasoning (p = 0.08). No differences were found between groups for attention, memory, or Clinical Dementia Rating scores.

Demarin V, Podobnik SS, Storga-Tomic D, et al. Drugs Exp Clin Res, 2004. PMID 15134388

2004 / Randomized controlled trial (follow-up phase)

Ceasing creatine during 12 weeks of reduced-volume resistance training did not affect strength, endurance, or lean tissue mass loss in older men.

Researchers evaluated the effects of stopping creatine supplementation during 12 weeks of reduced resistance training volume (33% lower volume) in older men who previously took creatine (n = 8) compared with men who did not (n = 5). Strength and lean tissue mass showed no changes in either group. Muscle endurance decreased significantly by 7-21% (p < .05), with a similar rate of change between groups. Withdrawing creatine had no effect on the rate of strength, endurance, or lean tissue mass changes during reduced training.

Candow DG, Chilibeck PD, Chad KE, et al. J Aging Phys Act, 2004. PMID 15263100

2004 / Randomized, double-blind, placebo-controlled trial

Daily vitamin E supplementation did not lower overall infection incidence, but fewer elderly nursing home residents acquired respiratory tract infections.

A randomized, double-blind, placebo-controlled trial tested daily supplementation of 200 IU vitamin E versus placebo for 1 year in 617 elderly nursing home residents. Vitamin E had no significant effect on overall incidence or number of days with infection for all, upper, or lower respiratory tract infections, or on antibiotic use. However, significantly fewer participants in the vitamin E group acquired 1 or more respiratory tract infections (60% vs 68%; RR 0.88; 95% CI, 0.76-1.00; P = .048) or upper respiratory tract infections (44% vs 52%; RR 0.84; 95% CI, 0.69-1.00; P = .05). In post hoc analyses among completers, vitamin E significantly reduced the incidence and risk of acquiring 1 or more common colds.

Meydani SN, Leka LS, Fine BC, et al. JAMA, 2004. PMID 15315997

2004 / Randomized controlled trial

Daily antioxidant, zinc, and copper supplementation showed no beneficial or harmful effect on cognition in older adults after nearly seven years.

Participants in the Age-Related Eye Disease Study were randomly assigned to receive daily antioxidants (500 mg vitamin C, 400 IU vitamin E, 15 mg beta carotene), zinc and copper (80 mg zinc, 2 mg cupric oxide), both, or placebo. A cognitive battery was administered to 2,166 elderly individuals after a median of 6.9 years of treatment. Treatment groups did not differ on any of the six cognitive tests (p > 0.05 for all), showing neither benefit nor harm on cognition.

Yaffe K, Clemons TE, McBee WL, et al. Neurology, 2004. PMID 15534261

2004 / 12-week, double-blind, placebo-controlled, split-face randomized clinical study

Topical 5% niacinamide significantly improved fine lines, wrinkles, hyperpigmentation, texture, red blotchiness, and skin yellowing in aging facial skin.

A 12-week, double-blind, placebo-controlled, split-face clinical study in 50 Caucasian females aged 40-60 years evaluated a moisturizer containing 5% niacinamide compared with a moisturizer control product. Niacinamide was well tolerated by the skin. Compared with the control product, 5% niacinamide provided significant improvements in fine lines/wrinkles, hyperpigmentation spots, texture, red blotchiness, and skin yellowing (sallowness).

Bissett DL, Miyamoto K, Sun P, et al. Int J Cosmet Sci, 2004. PMID 18492135

2003 / Double-blind, randomized controlled trial

Topical 5% vitamin C cream improved clinical scores, skin microrelief, and elastic tissue repair in women with photoaged skin over 6 months.

A 6-month randomized, double-blind trial compared daily topical application of a 5% vitamin C cream versus its excipient on photoaged skin of the low-neck and arms in healthy female volunteers. Clinical evaluations by a dermatologist and volunteer self-assessments revealed significant improvement in the global score on the vitamin C-treated side compared with control. Analysis demonstrated a highly significant increase in skin microrelief density, a decrease in deep furrows, and ultrastructural evidence of elastic tissue repair. The authors concluded that topical 5% vitamin C was effective and well-tolerated for improving photodamaged skin.

Humbert PG, Haftek M, Creidi P, et al. Exp Dermatol, 2003. PMID 12823436

2003 / Double-blind, randomized crossover trial

Oral L-arginine supplementation improved flow-mediated dilation and normalized the L-arginine/ADMA ratio in healthy adults over 70 years old.

Twelve healthy older adults (aged 73.8 +/- 2.7 years) received oral L-arginine (8 g twice daily) or placebo for 14 days each in a randomized crossover trial separated by a 14-day washout. L-Arginine significantly improved brachial flow-mediated dilation to 5.7 +/- 1.2% (p < 0.0001), whereas placebo showed no significant effect (-0.25 +/- 0.7%). Plasma L-arginine levels increased from 57.4 +/- 5.0 to 114.9 +/- 11.6 micromol/l after L-arginine supplementation. ADMA levels were elevated at baseline compared to middle-aged individuals (3.9 +/- 0.2 vs. 1.0 +/- 0.1 micromol/l; p < 0.0001) and remained unchanged, but L-arginine normalized the L-arginine/ADMA ratio (p < 0.05).

Bode-Böger SM, Muke J, Surdacki A, et al. Vasc Med, 2003. PMID 14518608

2002 / Randomized, double-blind, placebo-controlled 2 x 2 factorial trial

Neither multivitamin-minerals nor vitamin E reduced acute respiratory tract infections in elderly individuals, and vitamin E worsened illness severity.

A 2x2 factorial trial evaluated physiological doses of multivitamin-minerals, 200 mg vitamin E, both, or placebo over a median of 441 days in 652 noninstitutionalized individuals aged 60 or older. The incidence rate ratio for acute respiratory tract infections was 0.95 (95% CI, 0.75-1.15; P=.58) for multivitamin-minerals and 1.12 (95% CI, 0.88-1.25; P=.21) for vitamin E. Multivitamin-minerals did not influence severity, but vitamin E resulted in longer illness duration (median 19 vs 14 days, P=.02), more symptoms (median 6 vs 4, P=.03), more fever (36.7% vs 25.2%, P=.009), and more activity restriction (52.3% vs 41.1%, P=.02).

Graat JM, Schouten EG, Kok FJ JAMA, 2002. PMID 12169075

2002 / Sequential nonrandomized intervention study

Oral cobalamin at 1,000 mcg daily effectively normalized elevated methylmalonic acid levels in cobalamin-deficient older adults.

Researchers tested sequential 6-week daily treatments of 25 mcg, 100 mcg, and 1,000 mcg oral cobalamin in 23 older adults with cobalamin deficiency. Daily treatment with 25 mcg and 100 mcg lowered but did not normalize MMA levels in most participants, whereas 1,000 mcg/day was the most effective in lowering MMA to normal limits. Serum tHcy normalized in 6 of 11 participants with elevated baseline tHcy using oral cobalamin alone, and in 1 participant in combination with a multivitamin.

Rajan S, Wallace JI, Brodkin KI, et al. J Am Geriatr Soc, 2002. PMID 12410896

2001 / Pre-post intervention trial

Lactobacillus rhamnosus HN001 consumption increased cellular immune responses in older adults

In a three-stage trial of 52 healthy middle-aged and elderly volunteers, consuming 10^9 CFUs/g of Lactobacillus rhamnosus HN001 in milk for 3 weeks increased polymorphonuclear cell phagocytic activity by 19% in regular low-fat milk and 15% in lactose-hydrolyzed milk. Natural killer cell tumor killing activity also rose by 71% and 147%, respectively. Responses were not altered during the milk-only run-in period.

Sheih YH, Chiang BL, Wang LH, et al. J Am Coll Nutr, 2001. PMID 11349938